LONDON (AP) — Drug manufacturer GlaxoSmithKline says it has named a new chief for its operations in China amid an investigation there for possible bribery of doctors.
Chinese police say that four employees of GSK China are suspected of paying bribes to doctors and hospitals to encourage them to prescribe medications.
The U.K.-based company has distanced itself from the scandal, saying that four employees suspected of paying bribes were acting outside of company controls.
On Thursday, GSK said it has appointed Herve Gisserot as general manager for GSK China pharmaceuticals.
The company said Gisserot most recently served as a senior vice president for GSK's European business.